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Patients in intensive care units frequently suffer muscle weakness and atrophy due to critical illness poly-
neuropathy (CIP), an axonal neuropathy associated with systemic inflammatory response syndrome andmulti-
ple organ failure. CIP is a frequent and serious complication of intensive care that delays weaning from
mechanical ventilation and increases mortality. The pathogenesis of CIP is not well understood and no specific
therapy is available. The aim of this project was to use nerve excitability testing to investigate the changes
in axonal membrane properties occurring in CIP. Ten patients (aged 37–76 years; 7 males, 3 females) were
studied with electrophysiologically proven CIP. The median nerve was stimulated at the wrist and compound
action potentials were recorded from abductor pollicis brevismuscle. Strength–duration time constant, thresh-
old electrotonus, current–threshold relationship and recovery cycle (refractoriness, superexcitability and
late subexcitability) were recorded using a recently described protocol. In eight patients a follow-up investiga-
tion was performed. All patients underwent clinical examination and laboratory investigations. Compared with
age-matched normal controls (20 subjects; aged 38–79 years; 7 males, 13 females), CIP patients exhibited
reduced superexcitability at 7 ms, from 22.3 6 1.6% to 7.6 6 3.1% (mean 6 SE, P  0.0001) and increased
accommodation to depolarizing (P < 0.01) and hyperpolarizing currents (P < 0.01), indicating membrane
depolarization. Superexcitability was reduced both in patients with renal failure and without renal failure.
In the former, superexcitability correlated with serum potassium (R = 0.88), and late subexcitability was
also reduced (as also occurs owing to hyperkalaemia in patients with chronic renal failure). In patients without
renal failure, late subexcitability was normal, and the signs of membrane depolarization correlated with raised
serumbicarbonate and base excess, indicating compensated respiratory acidosis. It is inferred thatmotor axons
in these CIP patients are depolarized, in part because of raised extracellular potassium, and in part because of
hypoperfusion. The chronic membrane depolarization may contribute to the development of neuropathy.
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Introduction
Critical illness polyneuropathy (CIP) is a predominantly distal,
motor and sensory axonal polyneuropathy, affecting 30–70%
of critical care patients (Berek et al., 1996; Leijten et al., 1996;
Hund, 2001; Bolton, 2005; Latronico et al., 2005). It is often
revealed by failure of weaning from artificial ventilation and
contributes to mortality, rehabilitation problems and subse-
quent impaired quality of life (Zochodne et al., 1987). CIP is
strongly associated with systemic inflammatory response
syndrome and multiple organ dysfunction syndrome, but its
aetiology is not well understood (Bolton, 1996). CIP has been
attributed to either the build-up of neurotoxic factors in the
blood or the rapid depletion of essential factors, or to endo-
neurial hypoxia caused by oedema and reduced microvascular
blood flow (Druschky et al., 2001).
Nerve excitability testing is a non-invasive approach
to investigating the pathophysiology of peripheral nerve
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disorders, which determines the electrical properties of the
nerve membrane at the site of stimulation. A recently devel-
oped computer-controlled excitability testing protocol mea-
sures multiple excitability parameters within 10 min which
provide information about the axonal membrane potential,
ion channels and ionic environment (Kiernan et al., 2000).
For example, the technique has revealed membrane potential
changes in patients with chronic renal failure, and with multi-
focal motor neuropathy, that could not be detected by con-
ventional nerve conduction studies (Kiernan et al., 2002a, b).
Nerve excitability testing is therefore a highly appropriate
tool for investigating CIP, in which membrane depolarization
is a likely aetiological factor, whether caused by the toxic
action of cytokines, anoxia or endoneurial hyperkalaemia.
The present study was therefore undertaken to test the
hypothesis that axons in CIP patients are depolarized and
to compare abnormalities in excitability parameters with
putative contributors to nerve damage, to improve our
understanding of the pathophysiology and aetiology of this
condition and ultimately to help reduce its incidence.
Methods
Recordings were made on 10 patients (aged 37–76 years; mean:
62.2 years; 7 males, 3 females) from the intensive care unit of
two major London teaching hospitals. No patient had a history
of pre-existing peripheral neuropathy or myopathy or suffered
from a disease, such as diabetes mellitus, that is associated with
polyneuropathy or myopathy. All patients suffered from CIP. The
presence of CIP was assessed by clinical and electrophysiological
evaluation. The patients were compared with 20 healthy control
subjects (NC) with a similar age range (aged 38–79 years; mean:
58 years; 7 males, 13 females). (Blood gas and bicarbonate measure-
ments were not available for 10 subjects, but the smaller control
group used for comparing these parameters was otherwise similar to
the larger group, aged 38–78 years; mean: 55.6 years; 3 males, 7
females.) The study was approved by the St Thomas’ Hospital
Research Ethics Committee and by the National Hospital for Neu-
rology and Neurosurgery and the Institute of Neurology Joint
Research Ethics Committee. The consent of subjects or relatives
was obtained according to the Declaration of Helsinki.
Clinical investigations
Patients were clinically evaluated when a steady neurological state
had been achieved after interruption of sedative drugs and neuro-
muscular blocking agents. The clinical signs of CIP were progressive
muscle weakness with only minimal movement or complete
paralysis in response to speech or painful stimulation and reduced
or absent deep tendon reflexes. The clinical state of patients was
scored according to a functional disability score including a ranking
of the following clinical signs: deep tendon reflexes (0 = normal,
1 = reduced, 2 = absent), muscle weakness (0 = normal muscle force,
2 = mild, 3 = moderate and 4 = severe muscle weakness), muscle
atrophy (0 = absent, 1 = present) and muscle fasciculations (0 =
absent, 1 = present) as described earlier (Druschky et al., 2001).
Organ failure was classified using a modified Goris score (Goris
et al., 1985). Multiple organ failure was defined as severe dysfunction
of two or more organ systems including the cardiovascular, respira-
tory, haematological, hepatic, renal and gastrointestinal systems
(Witt et al., 1991; Druschky et al., 2001). Sepsis was defined as the
systemic inflammatory response to infection characterized by two
or more of the following conditions: (i) temperature >38C or
<36C; (ii) heart rate >90 beats/min; (iii) respiratory rate >20 breaths/
min or PaCO2 <4.27 kPa; (iv) white blood cell count >12 000/mm
3 or
<4000/mm3; (v) >10% immature forms (Bone et al., 1992).
Electrophysiological investigations
Nerve conduction studies were performed from the median, pero-
neal and sural nerves using conventional procedures. Measured
parameters were nerve conduction velocity, amplitudes of the com-
pound muscle action potentials (CMAPs) and amplitudes of sensory
nerve action potentials (SNAPs). Repetitive stimulation at 3 Hz of
the median nerve with recording from the abductor pollicis brevis
muscle was done in all patients to screen for neuromuscular trans-
mission defects, for example, due to neuromuscular blocking agents.
Concentric needle examinations were performed at multiple inser-
tion points including the abductor pollicis brevis and tibialis ante-
rior muscles. The diagnosis of CIP was established according to the
criteria published earlier (Bolton et al., 1984; Zochodne et al., 1987;
Bolton, 2005), on the basis of the finding of an acute motor and
sensory axonal dysfunction in at least two extremities.
Nerve excitability studies
Studies were performed using a recently described protocol (Kiernan
et al., 2000) designed to measure a number of different excitability
parameters rapidly. CMAPs were recorded from the abductor
pollicis brevis muscle using surface electrodes, with the active elec-
trode at the motor point and the reference electrode on the proximal
phalanx. The signal was amplified (gain: 1000, bandwidth:
1.6–2 kHz) and digitized by a data acquisition unit (Micro 1401,
Cambridge Electronic Design, Cambridge, UK) using a sampling
rate of 10 kHz. Stimulus waveforms generated by a computer
were converted to current with a purpose-built isolated linear bipo-
lar constant current stimulator (DS5 prototype, Digitmer Ltd.,
Welwyn Garden City, UK) (maximum output 6 50 mA). The sti-
mulus currents were applied via non-polarizable electrodes (Red
Dot, 3M Health Care, Borken, Germany), with the active electrode
over the median nerve at the wrist and reference electrode 10 cm
proximal over muscle. Stimulation and recording were controlled by
QTRAC software (copyright Institute of Neurology, London) with
multiple excitability protocol TRONDCM.
Test current pulses of 0.2–1 ms were applied at 0.8 s intervals
and combined with supra-threshold conditioning stimuli or sub-
threshold polarizing currents as required. The polarizing, condition-
ing and test current pulses were all delivered through the same
electrodes. The amplitude of the CMAP was measured from baseline
to negative peak. For all tracking studies, the target CMAP was set to
40% of maximal CMAP. Skin temperature was monitored over the
median nerve close to the site where axonal excitability was tested.
The sequence of recordings was similar to that described
previously (Kiernan et al., 2000), except for the determination
of the strength–duration relationship and refractory period of
transmission. Stimulus–response curves were recorded for test
stimuli of 1 ms duration (Fig. 1A). The stimuli were increased in
6% steps, with two responses averaged for each step, until three
averages were maximal. A target response was then set at 40% of
the maximum and the 1 ms test stimuli adjusted automatically by
the computer to maintain this peak CMAP amplitude. The test
stimulus amplitude required to excite the target response was
regarded as the threshold current for axons recruited at this level
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of response. ‘Proportional tracking’ was used whereby the change in
stimulus amplitude from one trial to the next was made propor-
tional to the ‘error’, or difference between the last response and the
target response (Bostock et al., 1998). The slope of the stimulus–
response curve was used to set the constant of proportionality and
to optimize the tracking efficiency.
The strength–duration relationship for the nerve was measured
by comparing the threshold current for a 1 ms test stimulus with the
threshold current for stimuli of 0.8, 0.6, 0.4 and 0.2 ms duration.
Threshold electrotonus (Bostock et al., 1998) was then measured by
recording the changes in threshold induced by 100 ms polarizing
currents, set to 620% and 640% of the control threshold current.
Five stimulus conditions were tested in turn: test stimulus alone
(to measure the control threshold current) and test stimulus plus
each of the four levels of polarizing current. Threshold was tested at
up to 26 time points (maximum separation: 10 ms) before, during
and after the 100 ms conditioning currents.
The current–threshold relationship was tested with 1 ms pulses
at the end of 200 ms polarizing currents, which were altered in
10% steps from +50% (depolarizing) to 100% (hyperpolarizing)
of the control threshold. Stimuli with conditioning currents were
alternated with test stimuli alone.
The recovery of excitability following a supramaximal condi-
tioning stimulus was tested at 18 conditioning–test intervals,
decreasing from 200 to 2 ms in geometric progression. Three sti-
mulus conditions were tested in turn: (i) unconditioned 1 ms test
stimulus to track the control threshold; (ii) 1 ms supramaximal
conditioning stimulus; (iii) conditioning plus test stimuli. The
response to (ii) was subtracted online from the response to (iii)
before the test CMAP was measured to avoid contamination of
the test CMAP by the conditioning one when the conditioning-
test interval was short.
The final part of the protocol recorded the refractory period of
transmission. Pairs of supramaximal stimuli were delivered at
conditioning–test intervals of 10, 7, 5, 4, 3, 2 and 1 ms to investigate
the time course of any changes in impulse transmission (Kuwabara
et al., 2003). The intensity of the conditioning stimulus was 20%
above that required for producing a maximal CMAP, and the second
stimulus was set 50% higher than the first. The conditioned CMAP
was measured after the response to the supramaximal conditioning
stimulus had been subtracted. The amplitude of the conditioned
CMAP was normalized to the unconditioned value.
Laboratory examinations
Laboratory examinations were performed either before or after, but
always within 90 min of the electrophysiological investigations, and
included serum levels of sodium, potassium, chloride, glucose,
Fig. 1 Nerve excitability changes in CIP. Means and standard error bars for data from 20 normal controls (open circles) and first recordings
from 10 patients in intensive care (filled circles). (A) Stimulus–response relationship (1 ms stimuli): circles at mean stimulus current for
half-maximal peak CMAP. (B) Charge–duration relationship, in which intercept on stimulus width axis gives strength–duration time
constant, and slope gives rheobase. (C) Threshold electrotonus for 100 ms polarizing currents, 640% of threshold. Responses to
depolarizing currents start above the line, and those to hyperpolarizing currents below the line. Standard error bars of many
depolarizing responses fall within the circles. (D) Recovery cycle following supramaximal stimulation.
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lactate, creatinine, C-reactive protein, arterial pO2, pCO2, bicarbo-
nate, base excess (BE) and pH.
Data analysis
The following excitability parameters were derived from each
recoding: resting current–threshold slope (the slope of the
current–threshold relationship, calculated from the polarizing cur-
rents between 10 and +10% of resting threshold); minimum
current–threshold slope (the minimum slope, calculated by fitting
a straight line to each three adjacent points in turn); relative refrac-
tory period (calculated from the recovery cycle data as the first
intercept on the x-axis); superexcitability (the interpolated threshold
change at an interstimulus interval of 7 ms N.B.; the normal measure
of superexcitability, that is, the minimum mean of three adjacent
points, was inappropriate for CIP patients, since in some cases there
was no minimum); subexcitability (the maximum mean of three
adjacent points of the recovery cycle); the threshold electrotonus
parameters TEd[10–20 ms], TEd[90–100 ms], TEh[90–100 ms]
[mean threshold reductions between the specified latencies for
the 40% depolarizing (TEd) and hyperpolarizing (TEh) currents]
and the refractory period of transmission (calculated as the interval
between the conditioning and test stimulus that causes a drop of the
amplitude of the conditioned CMAP of 50% compared with the
amplitude of the CMAP induced by the conditioning stimulus).
Data were compared using unpaired two-tailed t-tests. Relative
refractory period measurements were compensated for temperature
using the relationship found in normal control subjects (Kiernan
et al., 2000).
Results
Patients’ and control subjects’ characteristics, including mean
age, gender and clinical and laboratory characteristics are
summarized in Table 1. All patients fulfilled the electrophy-
siological criteria for CIP, with decreased amplitudes of
CMAPs in motor nerve conduction studies, fibrillation
potentials and positive sharp waves in electromyography
and severe depression (n = 3) or absence (n = 7) of SNAP
amplitudes (in the absence of tissue oedema). No patient
showed clinical or electrophysiological signs of neuro-
muscular transmission defect. All patients suffered multiple
organ failure or sepsis. In four patients these two entities were
combined. To determine which axonal properties are sig-
nificantly affected in CIP, the first recordings from each
patient (i.e. the 10 CIP-1 observations in Table 1) were com-
pared with the data from the similarly aged controls. When
possible, a second examination (CIP-2) was made 2 weeks
after the first, in case the development or progression
of neuropathy could be related to the earlier measurements.
In the event, the second examinations (average 15.1 6
4.7 days later, mean 6 SE) did not differ significantly from
the first, either in clinical and laboratory data (Table 1) or in
the nerve excitability measurements. For the purposes of
determining the mechanisms responsible for the changes
in excitability parameters, we combined the data from
both sets of patient recordings (i.e. the 10 CIP-1 and 8
CIP-2 observations listed in Table 1).
Nerve excitability data for the CIP patients (first record-
ings) and normal control subjects are compared in Figs 1
and 2. Thresholds for a half-maximal response (1 ms stimu-
lus) were higher in the patients (CIP-1: 10.0 6 1.8 mA,
mean 6 SE, n = 10; NC: 4.9 6 0.7, n = 20, P < 0.01) and
the maximal patient CMAPs were significantly smaller (CIP-
1: 3.7 6 0.9 mV; NC: 8.0 + 0.6 mV; P < 0.001) (Fig. 1A). The
most significant abnormalities in the CIP patients were a
‘fanning-in’ of threshold electrotonus (i.e. a reduction in
the absolute size of the threshold changes produced by
polarizing currents) (Fig. 1C) and a reduction in superexcit-
ability (Fig. 1D), both of which changes occur on membrane
depolarization (Kiernan and Bostock, 2000). Thus the early
depolarizing electrotonus, from 10 to 20 ms after a 40%
of threshold depolarizing current (TEd[10–20 ms]) was
Table 1 Clinical and laboratory characteristics of patients with CIP and normal control subjects
Normal control subjects CIP-1 CIP-2 P-value
ANOVA t-test Wilcoxonw
Numbers of patients 20 10 8
Age (years) 58.0 6 3.2 62.2 6 3.72 60.75 6 4.71 0.71
Male/female 7/13 3/7 3/5
FDS 0 3 (range: 1–6) 3 (range: 1–4) 0.71w
MOF 0 2 (range: 1–3) 2.5 (range: 2–4) 0.41w
Sepsis 0 5 5
Potassium 4.01 6 0.08 4.32 6 0.15 4.15 6 0.11 0.11 0.17
Creatinine 73.7 6 3.0 120.6 6 34.08 94.25 6 31.47 0.22 0.49
CRP 3.3 6 0.3 121.3 6 26.01 75.0 6 26.5 0.00001***** 0.58
pO2 9.91 6 0.23 (n = 10) 11.01 6 7.8 11.32 6 0.85 0.3 0.78
pCO2 4.44 6 0.21 (n= 10) 5.84 6 0.34 5.68 6 035 0.005** 0.77
pH 7.44 6 0.01 (n= 10) 7.42 6 0.01 7.44 6 0.01 0.39 0.95
BE 0.66 6 0.66 (n= 10) 2.35 6 0.87 3.94 6 1.21 0.005** 0.67
Bicarbonate 22.32 6 0.8 (n= 10) 27.15 6 0.82 29.24 6 1.83 0.001*** 0.22
ANOVA (analysis of variance) compares all three groups, whereas paired t-test or Wilcoxon matched pairs test compares measurements on
CIP patients. Values are given as mean 6 SEM; values of FDS and MOF are given as median and range (*P < 0.05, **P < 0.01, ***P < 0.001,
****P < 0.0001, *****P< 0.00001). FDS = functional disability score; MOF = multiple organ failure; CRP = C-reactive protein.
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reduced from 70.1 6 1.4% to 58.3 6 2.4% (P < 0.001) and
depolarizing electrotonus at 90–100 ms (TEd[90–100 ms])
was reduced from 46.6 6 1.2% to 39.6 6 2.2% (P < 0.01).
Hyperpolarizing electrotonus at 90–100ms (TEh[90–100ms])
was reduced from 131.0 6 4.9% to 95.7 6 8.8% (P <
0.001). Superexcitability at 7 ms was reduced by two-thirds,
from 22.3 6 1.6% to 7.6 6 3.1% (P  0.0001). The
changes in most other excitability parameters were also con-
sistent with depolarization (Kiernan and Bostock, 2000). The
relative refractory period was increased from 2.8 6 0.09% to
3.9 6 0.5% (P < 0.01), and the strength–duration time con-
stants were longer in the patients, but not significantly so
(CIP-1: 0.44 6 0.05 ms; NC: 0.41 6 0.02 ms; P = 0.44)
(Fig. 1B). The current–threshold relationship, the threshold
analogue of the current–voltage (I/V) relationship, is shown
in Fig. 2A, and the slope of this curve, which is the threshold
analogue of conductance, is plotted in Fig. 2B. The resting
slope was increased in the patients (CIP-1: 0.93 6 0.22; NC:
0.57 6 0.02; P < 0.05) consistent with membrane depolariza-
tion (Kiernan and Bostock, 2000). Perhaps the clearest evi-
dence for depolarization is that the ‘I/V slope’ in Fig. 2B is
shifted to the left in the patients; the threshold analogue of a
shift of the conductance changes to more negative potentials
[or of the resting potential (Er) to a more depolarized value,
at which the slope is higher].
Although there was overlap between the control and
CIP groups for all excitability parameters, 7 of the 18 mea-
surements of superexcitability and 5 of the 18 measurements
of TEd[10–20 ms] in CIP patients fell outside the 95%
confidence limits for a healthy subject.
Nerve excitability changes and renal failure
In previous excitability studies it has been found that
the phase of late subexcitability in the recovery cycle can
provide evidence about the mechanism of membrane
depolarization, since it is generated by outward potassium
currents and depends on the difference between the mem-
brane potential and the potassium equilibrium potential
(Ek). Thus, depolarization by applied currents (without
changing extracellular potassium) increases late subexcitabil-
ity (Kiernan and Bostock, 2000), depolarization by hyperka-
laemia reduces late subexcitability (Kiernan et al., 2002b) and
depolarization by acute ischaemia occurs with little or no
change in late subexcitability (Kiernan and Bostock, 2000).
In the 18 recordings from patients with CIP, subexcitability
was unchanged on average (CIP-All: 10.7 6 1.6; NC: 12.2 6
1.1; P = 0.41), suggesting that depolarization was accompa-
nied by a small increase in extracellular potassium, as occurs
in acute ischaemia. However, we found that there was a
significant correlation between late subexcitability and crea-
tinine (R = 0.67, P < 0.005), and when the patient recordings
were subdivided into 7 with evidence of renal failure (CIPRF+,
creatinine > 100 mM) and 11 without (CIPRF, creatinine <
100 mM), there was a significant reduction of late subexcit-
ability in the recordings from patients with renal failure, but
not in those without (CIPRF+: 7.9 6 1.2, P < 0.05; CIPRF:
13.1 6 0.9, P = 0.59). This provides evidence that intra-
neural potassium was high in the patients with renal failure.
In contrast, superexcitability and electrotonus markers for
membrane depolarization were not significantly different
between the patients with renal failure and those without
(Fig. 3), so that potassium was unlikely to be responsible
for the depolarization in the majority of patients without
renal failure.
The close relationship between membrane potential and
extracellular potassium levels in the patients with renal failure
is shown more directly by plotting the potential-sensitive
excitability parameters superexcitability and TEd[10–20 ms]
against serum potassium in Fig. 4. All the ellipses, in normal
Fig. 2 Mean current–threshold relationship (A) and its slope (B) for patients (filled circles) and normal controls (open circles). The slope of
the current–threshold relationship is the threshold analogue of conductance, and increases on depolarization (to the right of vertical line),
owing to activation of outwardly rectifying potassium channels, and also on extreme hyperpolarization (far left), owing to activation of
inwardly rectifying IH. Patient curve is displaced to the left, indicating that rectifying channels are relatively depolarized.
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controls as well as both patient groups, show a similar slope,
corresponding to membrane depolarization with an increase
in serum potassium, but only in the patients with renal failure
are the correlations significant.
Nerve excitability and chronic respiratory
acidosis
Table 1 shows that whereas pH was normal in the patients,
serum levels of pCO2, BE, bicarbonate and corrected anion
gap were abnormally high. This indicates that the patients
were suffering from chronic respiratory acidosis, combined
with metabolic alkalosis. When each of these levels was tested
for correlation with the excitability parameters within the
18 patient recordings, only bicarbonate and BE showed
significant correlations with multiple excitability indices of
membrane potential. Excitability indices of membrane
potential correlated with serum bicarbonate levels, but
only in the patients without renal failure. Figure 5 is analo-
gous to Fig. 4, with bicarbonate replacing potassium as
the abscissa, and shows a complementary relationship:
whereas in patients with kidney failure membrane potential
was strongly related to serum potassium, in patients with
preserved kidney function membrane potential is more
closely related to serum bicarbonate, and therefore to the
chronic respiratory acidosis.
Nerve excitability changes and other
factors
We have seen evidence that the membrane depolarization in
CIP patients is related to extracellular potassium in patients
with renal failure and to respiratory acidosis in those without.
Here, we test whether these two factors together can account
for the membrane depolarization, or whether other factors,
such as the unknown toxic factors previously hypothesized,
are likely to be involved. Table 2 shows the fraction of the
variance in excitability parameters accounted for by cor-
relation with serum potassium, serum bicarbonate and
skin temperature, and by multiple correlations with all
three variables combined. Temperature is included, since
relative refractory period is known to be particularly sensitive
to temperature. The analysis is performed for the combined
group of patients and controls, as well as for the separate
patient and control groups, since we are interested in factors
accounting for the differences between patients and controls,
Fig. 3 Excitability parameters and their relationship to renal failure in CIP. Electrotonus and recovery cycle parameters
compared for 20 normal control (NC) and 18 CIP recordings, as a whole and separated into 7 with renal failure (RF+) and 11
without (RF). Values plotted are means with standard error bars. Labels on columns 2–4 indicate probabilities that values are
drawn from the same population as NC. NS = not significant (P > 0.05), *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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as well as the variation within the patient group. Consistent
with the results reported above, among the patients early
depolarizing threshold electrotonus is significantly correlated
with serum potassium in those with renal failure, and with
bicarbonate in those without renal failure, but the com-
bination of potassium and bicarbonate accounts for over
50% of the variance, and for almost 70% of the variance
in the combined group of patients and controls. For the
other strongly potential-dependent excitability parameters,
such as superexcitability, a high proportion of the variance
is also explained by correlation with the same two variables.
These figures indicate that any independent factor can only
account for a relatively small fraction of the changes in
membrane potential. For example, C-reactive protein, an
indicator of acute inflammation, might have been expected
to correlate with neurotoxic factors affecting nerve excitabil-
ity (Druschky et al., 2001). However, there was no significant
correlation between C-reactive protein levels and any of
the excitability parameters in the patients.
Discussion
CIP was first described in 1984 (Bolton et al., 1984) and
has subsequently become widely recognized as a common
polyneuropathy, occurring in 50–70% of patients who are
critically ill or injured (Berek et al., 1996; Leijten et al.,
1996; Hund, 2001). Such patients have a syndrome now
termed the systemic inflammatory response syndrome
(Bolton, 1996). This syndrome occurs in response to both
infection and several forms of trauma, including major
surgery and has been attributed to humoral neurotoxic
factors (Druschky et al., 2001). After the development of
systemic inflammatory response syndrome in a critical care
unit, the earliest nervous system manifestation is encephalo-
pathy, which can gradually progress to deep coma. If
the syndrome responds to treatment (antibiotics, surgical
drainage of an infected focus, supportive measures) the
encephalopathy usually improves rapidly, but at this time
difficulty in weaning from the ventilator will be noted.
Studies have shown that the most common neuromuscular
cause for such weaning difficulty is CIP (Zochodne et al.,
1987; Lemaire, 1993). However, clinical signs of polyneuro-
pathy are present in only half of these patients. Hence
electrophysiological studies are necessary for establishing
the diagnosis. The morphological features of CIP have
been revealed through biopsy of peripheral nerve and muscle
and a comprehensive autopsy study (Zochodne et al., 1987).
These studies indicate primary distal axonal degeneration of
Fig. 4 Excitability parameters related to serum potassium and renal failure. In each plot, circles represent subset of CIP recordings (filled
circles: with renal failure, open circles: without renal failure), dashed ellipses are 95% confidence limits for the group, and R-values are
correlation coefficients (*P < 0.05, **P < 0.01). Solid ellipses indicate mean 6 standard deviation of normal controls (68% limits).
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peripheral motor and sensory nerve fibres, but up to now the
aetiology of the axonal neuropathy has remained unclear.
The current diagnostic criteria for CIP require patient
history, clinical data and electrophysiological evidence of
an axonal motor and sensory polyneuropathy (Bolton,
2005). The differential diagnosis of CIP includes other
neuromuscular transmission defects and myopathies, of
which the most important one is critical illness myopathy.
According to neurophysiological (Rich et al., 1997) and
biopsy (Latronico et al., 1996) studies, myopathies occur
much more frequently during critical illness than previously
recognized. Three main types, often termed together as acute
quadriplegic myopathy or acute myopathy of intensive care,
have been identified: a diffuse non-necrotizing myopathy
(‘critical illness myopathy’), myopathy with selective loss
of thick (myosin) filaments and the acute necrotizing
myopathy of intensive care (Hund, 1999). Differentiating
CIP from critical illness myopathy is difficult, and sometimes
these two syndromes can occur simultaneously. Both entities
show low CMAP amplitudes in motor nerve conduction
studies. Furthermore, needle electromyography is of little
use in distinguishing between myopathy and polyneuropathy,
because fibrillation potentials and positive sharp waves as
well as decreased recruitment can be present in CIP and in
critical illness myopathy. Stimulation of muscle directly and
indirectly (by stimulating the nerves to the muscle) may
provide some more information, but a reliable diagnosis
can only be achieved after muscle and/or nerve biopsy
(Sander et al., 2002; Bolton, 2005; Latronico et al., 2005).
Depression or absence of SNAP amplitudes (in the absence
of severe tissue oedema) is a strong indicator of CIP, since
SNAP amplitudes are normal in pure critical illness myopa-
thy. In the present study, all patients showed abnormally
small SNAPs, and in 7 out of the 10 patients SNAPs were
unrecordable, although the recording conditions were good.
This finding, coupled with the fact that none of our patients
had a previously documented polyneuropathy or suffered
from a systemic disease known to be strongly associated
with polyneuropathy, indicates the presence of CIP. This
does not exclude the possibility that an accompanying critical
illness myopathy may have contributed to the patients’
weakness. However, since nerve excitability tests study
nerve alterations at the site of stimulation, and do not depend
on the state of the muscle (provided CMAPs are
recordable), the possible simultaneous occurrence of critical
illness myopathy could not influence our measurements of
nerve excitability.
Our results provide evidence that axons are depolarized in
the CIP patients, and the excitability measurements also
provide some interesting clues as to the likely mechanisms
underlying membrane depolarization. In view of the
previous evidence linking renal failure to depolarization via
Fig. 5 Excitability parameters related to serum bicarbonate and renal failure, plotted as in Fig. 4.
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hyperkalaemia (Kiernan et al., 2002b; Krishnan et al., 2005),
and the high frequency of renal failure in critical care patients,
there were strong a priori reasons for supposing that hyperka-
laemia should be involved. However, there was little evidence
from the mean serum potassium level (4.24 mM, n = 18) that
hyperkalaemia could account for an appreciable degree of
membrane depolarization. That leaves us with the question
of what was the level of potassium in the tissues, especially
in the vicinity of the axons. The best indicator of endoneurial
potassium from nerve excitability measurements is the phase of
late subexcitability in the recovery cycle. This occurs reliably in
normal motor axons, owing to the activation of slow potassium
channels during the action potential (Schwarz et al., 1995).
These channels inactivate slowly, so that they normally generate
a late hyperpolarizing after-potential and period of subexcit-
ability, since the potassium equilibrium potential (Ek) is more
negative than the resting potential (Er). The subexcitability
therefore depends on the difference between these quantities:
Er-Ek. Thus, subexcitability increases when an axon is
depolarized by applied currents (Kiernan and Bostock,
2000), which make Er more positive without changing
Ek, and subexcitability decreases when an axon is depolarized
by extracellular potassium, which makes Ek more positive. In
the CIP patients subexcitability was inversely correlated with
creatinine, suggesting that renal insufficiency resulted in
raised intraneural potassium, even though serum potassium
remained relatively normal. (A direct effect of creatinine on
the slow potassium channels can be excluded, since no such
relationship was seen in the earlier study of patients with
renal failure.) We therefore hypothesize that in the patients
with renal insufficiency raised levels of endoneurial potas-
sium contribute to the membrane depolarization and hence
to the pathogenesis of CIP. In support of this, in spite of
the small range of values, there was a significant correlation
between serum potassium and excitability parameters in
the patients with renal insufficiency (Fig. 4) (see also Table 2).
In patients without renal failure superexcitability was
reduced to the same degree as in patients with additional
renal failure, whereas late subexcitability in the recovery
cycle was unchanged compared with normal control subjects.
This finding provides evidence of another mechanism of
membrane depolarization than in patients with additional
acute renal failure. Similar changes of superexcitability and
unchanged late subexcitability have been reported previously
in acute ischaemia (Kiernan and Bostock, 2000). Further-
more, significant correlations between superexcitability or
TEd[10–20 ms] and the measured serum bicarbonate and
BE were present in this patient group (Fig. 5). Although
pH was within normal limits in all patients, pCO2, bicarbo-
nate, BE and corrected anion gap were moderately to
abnormally raised. These findings suggest a mixed acid–
base disorder consisting of compensated respiratory acidosis
and metabolic alkalosis in these patients. The question arises
of whether the increase in pCO2, by causing intracellular
acidification, was thereby somehow responsible for the
membrane depolarization. This seems unlikely, since a
high concentration of pCO2 has been found to cause a
‘fanning-out’, rather than a ‘fanning-in’ of electrotonus, by
blocking potassium channels (Grafe et al., 1994). A more
plausible interpretation is that the reason why membrane
depolarization is related to bicarbonate and pCO2 is that
both depolarization and respiratory acidosis are caused by
poor oxygenation of the tissues. This was not evident from
the recorded pO2 values, because pO2 was maintained by
artificial ventilation and/or oxygen treatment. Furthermore,
all patients of this study suffered from systemic hypotension
during their stay in intensive care, and were therefore treated
with noradrenalin to maintain a sufficient systemic blood
pressure. The combination of these factors probably leads
to a further hypoperfusion of the small capillaries of the
nerves and via a local lack of oxygen to an accumulation
of acidic metabolites.
The degree of membrane depolarization seen in the
axons of the CIP patients was similar to that reported pre-
viously in patients with chronic renal failure (Kiernan et al.,
2002b). It was hypothesized that the chronic membrane
depolarization might be instrumental in causing the axonal
damage of uraemic neuropathy, by interfering with potential-
dependent mechanisms of ionic homeostasis (e.g. Na+/Ca2+
exchange) essential for cellular viability (Kiernan et al., 2002b;
Bostock et al., 2004). On this basis, it seems reasonable to
propose that in the critically ill patients the chronic axonal
membrane depolarization due to hyperkalaemia and/or
Table 2 Coefficients of determination (R2) for regression
of excitability parameters on three environmental
factors, and for multiple regressions on all three factors
combined
Serum
potassium
Serum
bicarbonate
Skin
temperature
Three
variables
Superexcitability
NC 0.186 0.088 0.003 0.33
CIP 0.211 0.296* 0.005 0.462**
NC + CIP 0.265** 0.494** 0.006 0.615*****
TEd (10–20 ms)
NC 0.311* 0.398* 0.162 0.622*
CIP 0.245* 0.298* 0.031 0.527**
NC + CIP 0.313*** 0.552**** 0.046 0.696*****
TEd (90–100 ms)
NC 0.151 0.074 0.079 0.154
CIP 0.173 0.195 0.015 0.354*
NC + CIP 0.221** 0.356** 0.028 0.456***
TEh (90–100 ms)
NC 0.355** 0.098 0.167 0.736**
CIP 0.247* 0.07 0.009 0.314*
NC + CIP 0.339*** 0.242** 0.007 0.461***
RRP
NC 0.181 0.014 0.048 0.473
CIP 0.274 0.004 0.452** 0.594**
NC + CIP 0.269** 0.122 0.261** 0.602****
NC = normal control, CIP = patients with critical illness
polyneuropathy, RRP = relative refractory period, *P < 0.05,
**P < 0.01, ***P < 0.001, ****P < 0.0001, *****P < 0.00001.
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hypoperfusion may also be involved in the pathophysiology
of the neuropathy. This would be consistent with the findings
of Latronico et al. (1996) that most sensory nerves in early
biopsies (median: 15 days sepsis) looked normal, despite
having reduced SNAPs, while in late biopsies (56 days)
electrophysiological and histological findings were concor-
dant. They suggested that early impairment of axonal
transport and transmembrane potential preceded structural
damage.
In conclusion, we have found evidence that in these CIP
patients peripheral nerves are depolarized, and the cor-
relations with serum factors suggest that this membrane
depolarization is related to endoneurial hyperkalaemia
and/or hypoxia. While other mechanisms of depolarization
may well be involved, the degree to which potential-sensitive
nerve excitability indices are related to serum potassium
and bicarbonate suggests that other factors, independent of
potassium and acid–base balance, are likely to be of relatively
minor significance.
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